Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin

Colloids and Surfaces B: Biointerfaces

Volumn 140, Issue , 2016, Pages 161-168

  Kim, Sanghoon ^a   Diab, Roudayna ^a   Joubert, Olivier ^b   Canilho, Nadia ^a   Pasc, Andreea ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Bioavailability; Caco 2 cells; Core shell mesoporous silica; Curcumin

Indexed keywords

BIOCHEMISTRY; CELLS; CYTOLOGY; GAS ADSORPTION; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MESOPOROUS MATERIALS; NANOPARTICLES; SILICA; TRANSMISSION ELECTRON MICROSCOPY; X RAY SCATTERING;

BIOAVAILABILITY; CACO-2 CELLS; CONFOCAL LASER SCANNING MICROSCOPY; CORE-SHELL MICROCAPSULES; CURCUMIN; MESOPOROUS SILICA; POORLY SOLUBLE DRUGS; SOLID LIPID NANOPARTICLE (SLN);

SHELLS (STRUCTURES);

CURCUMIN; MESOPOROUS SILICA NANOPARTICLE; NITROGEN; SOLID LIPID NANOPARTICLE; LIPID; MICROCAPSULE; NANOPARTICLE; SILICON DIOXIDE;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; CACO 2 CELL LINE; CONCENTRATION (PARAMETERS); CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DESORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROCAPSULE; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; X RAY CRYSTALLOGRAPHY; CACO-2 CELL LINE; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; ENDOCYTOSIS; ORAL DRUG ADMINISTRATION; POROSITY; PROCEDURES; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; CACO-2 CELLS; CAPSULES; CELL SURVIVAL; CURCUMIN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; ENDOCYTOSIS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPIDS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; POROSITY; SILICON DIOXIDE;

EID: 84952649522     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.12.040     Document Type: Article

References (49)

1. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 2006, 78:2081-2087.
2. Ammon H., Wahl M. Pharmacology of Curcuma longa. Planta Med. 1991, 57:1-7.
3. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997, 15:1867-1876.
4. Lin J.K., Pan M.H., Lin-Shiau S.Y. Recent studies on the biofunctions and biotransformations of curcumin. Biofactors 2000, 13:153-158.
5. Pfeiffer E., Höhle S., Solyom A.M., Metzler M. Studies on the stability of turmeric constituents. J. Food Eng. 2003, 56:257-259.
6. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
7. Yang K.-Y., Lin L.-C., Tseng T.-Y., Wang S.-C., Tsai T.-H. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J. Chromatogr. B 2007, 853:183-189.
8. Li L., Braiteh F.S., Kurzrock R. Liposome-encapsulated curcumin. Cancer 2005, 104:1322-1331.
9. Chen Y., Wu Q., Zhang Z., Yuan L., Liu X., Zhou L. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 2012, 17:5972-5987.
10. Tang H., Murphy C.J., Zhang B., Shen Y., Van Kirk E.A., Murdoch W.J., Radosz M. Curcumin polymers as anticancer conjugates. Biomaterials 2010, 31:7139-7149.
11. Sun Z.-J., Sun B., Tao R.-B., Xie X., Lu X.-L., Dong D.-L. A poly(glycerol-sebacate-curcumin) polymer with potential use for brain gliomas. J. Biomed. Mater. Res. 2012, 101A:253-260.
12. Yang X., Li Z., Wang N., Li L., Song L., He T., Sun L., Wang Z., Wu Q., Luo N., Yi C., Gong C. Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo. Sci. Rep. 2015, 5:10322-10337.
13. Song L., Shen Y., Hou J., Lei L., Guo S., Qian C. Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation. Colloids Surf. A 2011, 390:25-32.
14. Sindhu K., Rajaram A., Sreeram K.J., Rajaram R. Curcumin conjugated gold nanoparticle synthesis and its biocompatibility. RSC Adv. 2014, 4:1808-1818.
15. Salem M., Xia Y., Allan A., Rohani S., Gillies E.R. Curcumin-loaded, folic acid-functionalized magnetite particles for targeted drug delivery. RSC Adv. 2015, 5:37521-37532.
16. Sun J., Bi C., Chan H.M., Sun S., Zhang Q., Zheng Y. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surf. B 2013, 111:367-375.
17. Kakkar V., Muppu S.K., Chopra K., Kaur I.P. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur. J. Pharm. Biopharm. 2013, 85:339-345.
18. Guri A., Gülseren I., Corredig M. Utilization of solid lipid nanoparticles for enhanced delivery of curcumin in cocultures of HT29-MTX and Caco-2 cells. Food Funct. 2013, 4:1410-1419.
19. 2 using DNA or molecular biomarkers as triggering stimuli. ACS Nano 2013, 7:8455-8468.
20. Slowing I.I., Trewyn B.G., Giri S., Lin V.S.Y. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv. Funct. Mater. 2007, 17:1225-1236.
21. Slowing I., Vivero-Escoto J., Wu V., Lin Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60:1278-1288.
22. Kim S., Philippot S., Fontanay S., Duval R., Lamouroux E., Canilho N., Pasc A. pH- and glutathione-responsive release of curcumin from mesoporous silica nanoparticles coated using tannic acid-Fe(III) complex. RSC Adv. 2015, 5:90550-90558.
23. Tang F., Li L., Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv. Mater. 2012, 24:1504-1534.
24. http://www.accessdata.fda.gov/scripts/cder/iig/index.Cfm.
25. 2 core/shell nanoparticles: the silica coating regulations with a single core for different core sizes and shell thicknesses. Chem. Mater. 2012, 24:4572-4580.
26. Guerrero-Martínez A., Pérez-Juste J., Liz-Marzán L.M. Recent progress on silica coating of nanoparticles and related nanomaterials. Adv. Mater. 2010, 22:1182-1195.
27. 4:Yb,Tm at SiO-PEG nanoparticles. ACS Appl. Mater. Interfaces 2015, 7:14992-14999.
28. Lai J., Shah B.P., Zhang Y., Yang L., Lee K. Real-time monitoring of ATP-responsive drug release using mesoporous-silica-coated multicolor upconversion nanoparticles. ACS Nano 2015, 9:5234-5245.
29. Pasc A., Blin J.-L., Stébé M.-J., Ghanbaja J. Solid lipid nanoparticles (SLN) templating of macroporous silica beadsd lipid nanoparticles (SLN) templating of macroporous silica beads. RSC Adv. 2011, 1:1204-1206.
30. Ravetti-Duran R., Blin J.-L., Stébé M.-J., Castel A., Pasc Tuning the morphology and the structure of hierarchical meso-macroporous silica by dual templating with micelles and solid lipid nanoparticles (SLN). J. Mater. Chem. 2012, 22:21540-21548.
31. Kim S., Stébé M.-J., Blin J.-L., Pasc A. pH-controlled delivery of curcumin from a compartmentalized solid lipid nanoparticle@mesostructured silica matrix. J. Mater. Chem. B 2014, 2:7910-7917.
32. Blin J.-L., Jacoby J., Kim S., Stébé M.-J., Canilho A., Pasc A meso-macro compartmentalized bioreactor obtained through silicalization of green double emulsions: W/O/W and W/SLNs/W. Chem. Commun. 2014, 50:11871-11874.
33. Kim S., Durand P., Roques-Carmes T., Eastoe A., Pasc Metallo-solid lipid nanoparticles as colloidal tools for meso-macroporous supported catalysts. Langmuir 2015, 31:1842-1849.
34. Zhang Y., Wang J., Bai X., Jiang T., Zhang Q., Wang S. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol. Pharm. 2012, 9:505-513.
35. Zhao Z., Gao Y., Wu C., Hao Y., Zhao Y., Xu J. Development of novel Core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets. Drug Dev. Ind. Pharm. 2015, 30:1-10.
36. Lodha A., Lodha M., Patel A., Chaudhuri J., Dalal J., Edwards M., Douroumis D. Synthesis of mesoporous silica nanoparticles and drug loading of poorly water soluble drug cyclosporin A. J. Pharm. Bioallied. Sci. 2012, 4:92-94.
37. Leung M.H.M., Colangelo H., Kee T.W. Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. Langmuir 2008, 24:5672-5675.
38. Canilho N., Pasc A., Emo M., Stébé M.-J., Blin J.-L. Electrostatic vs. covalent bond in modified Jeffamine: effect on the phase behaviour and on the templating of mesoporous silica. Soft Matter 2013, 9:10832-10840.
39. Borenfreund E., Babich N., Martin-Alguacil Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests. Toxicol. In Vitro 1988, 2:1-6.
40. Ke D., Wang X., Yang Q., Niu Y., Chai S., Chen Z., An X., Shen W. Spectrometric study on the interaction of dodecyltrimethylammonium bromide with curcumin. Langmuir 2011, 27:14112-14117.
41. Wang Z., Leung M.H.M., Kee T.W., English D.S. The role of charge in the surfactant-assisted stabilization of the natural product curcumin. Langmuir 2010, 26:5520-5526.
42. Zimmermann E., Müller R.H. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media. Eur. J. Pharm. Biopharm. 2001, 52:203-210.
43. Feldman M., Barnett C. Fasting gastric pH and its relationship to true hypochlorhydria in humans. Digest. Dis. Sci. 1991, 36:866-869.
44. Costa P., Sousa Lobo J.M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13:123-133.
45. Sambuy Y., De Angelis I., Ranaldi G., Scarino M.L., Stammati A., Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol. 2005, 21:1-26.
46. http://www.fda.gov/downloads/drugs/guidance/ucm070246.
47. He Q., Zhang Z., Gao Y., Shi J., Li Y. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small 2009, 5:2722-2729.
48. Jambhrunkar S., Karmakar S., Popat A., Yu M., Yu C. Mesoporous silica nanoparticles enhance the cytotoxicity of curcumin. RSC Adv. 2014, 4:709-712.
49. Gangwar R.K., Tomar G.B., Dhumale V.A., Zinjarde S., Sharma R.B., Datar S. Curcumin conjugated silica nanoparticles for improving bioavailability and its anticancer applications. J. Agric. Food Chem. 2013, 61:9632-9637.